Efficacy/safety Of Ocrelizumab In Relapsing-remitting MS Patients With Suboptimal Response To Prior Disease-modifying Therapies (1-yr Interim Results)

Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/31461

Title:	Efficacy/safety Of Ocrelizumab In Relapsing-remitting MS Patients With Suboptimal Response To Prior Disease-modifying Therapies (1-yr Interim Results)
Authors:	Vermersch, P. Eralinna, J. Nicholas, R. Oreja-Guevara, C. Siva, A. VAN WIJMEERSCH, Bart Wiendl, H. Buffels, R. Wei, W. Comi, G.
Issue Date:	2020
Publisher:	SAGE PUBLICATIONS LTD
Source:	MULTIPLE SCLEROSIS JOURNAL, 26 (1_SUPPL) , p. 32 -32
Document URI:	http://hdl.handle.net/1942/31461
ISI #:	WOS:000532412600068
Rights:	2020 by SAGE Publications.
Category:	M
Type:	Journal Contribution
Appears in Collections:	Research publications

File	Description	Size	Format
vermersch_2020.pdf Restricted Access	Published version	107.04 kB	Adobe PDF	View/Open Request a copy

Check